AI: Article sounds Interesting
Loading...

India will get 50% of Oxford Coronavirus vaccine doses produced; Serum Institute of India will start Phase 3 trials of vaccine in August: Adar Poonawalla

Adar Poonawalla shared that he is hopeful of that 300 million doses of the vaccine candidate ‘Covidshield’, developed by the Oxford University will be manufactured by December 2020.

Published 188 days ago


Read Details


Was this page helpful?

Yes Yes! this solution to the problem was helpful. No No! this solution to the problem was not helpful.. Leave ErnesTech Feedback.Feedback
Loading...



© 2020 - ErnesTech - Privacy